Home › Funds › WYNNEFIELD CAPITAL INC › LFCR
WYNNEFIELD CAPITAL INC position in LFCR
LIFECORE BIOMEDICAL INC · Health Care
WYNNEFIELD CAPITAL INC reported holding 4,867,816 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q3 2026 13F filing — a position valued at US$32.0M, representing 26.30% of its reported portfolio and ranking #1 among its reported holdings. WYNNEFIELD CAPITAL INC has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How WYNNEFIELD CAPITAL INC's LFCR position evolved
WYNNEFIELD CAPITAL INC first disclosed a stake in LFCR in Q3 2023 at 4,923,545 shares (US$37.1M). The position peaked in Q4 2025 at 4,703,216 shares, worth US$38.5M. Across 13 filings, WYNNEFIELD CAPITAL INC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 4,867,816 shares valued at US$32.0M — an increase of 164,600 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.92M | $37.15M | New |
| Q4 2023 | 4.92M | $30.48M | Hold |
| Q1 2024 | 4.92M | $26.14M | Hold |
| Q2 2024 | 4.92M | $25.23M | Hold |
| Q3 2024 | 4.92M | $24.25M | Hold |
| Q4 2024 | 4.70M | $34.94M | Reduce |
| Q1 2025 | 4.70M | $33.11M | Hold |
| Q2 2025 | 4.70M | $38.19M | Hold |
| Q3 2025 | 4.70M | $34.62M | Hold |
| Q4 2025 | 4.70M | $38.47M | Hold |
| Q1 2026 | 4.70M | $17.50M | Hold |
| Q2 2026 | 4.70M | $24.69M | Hold |
| Q3 2026 | 4.87M | $32.03M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LFCR and 13F data
LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 23 other funds we track also report a position in LFCR — the largest reported positions include Legion Partners Asset Management, LLC (US$29.5M), 325 CAPITAL LLC (US$19.1M), Greenhaven Road Investment Management, L.P. (US$18.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LFCR
- Legion Partners Asset Management, LLC 4.48M sh · $29.49M · Q3 2026
- 325 CAPITAL LLC 2.90M sh · $19.05M · Q3 2026
- Greenhaven Road Investment Management, L.P. 2.87M sh · $18.88M · Q3 2026
- DCF Advisers, LLC 376.50K sh · $2.48M · Q3 2026
- WITTENBERG INVESTMENT MANAGEMENT, INC. 305.31K sh · $2.01M · Q3 2026
More on WYNNEFIELD CAPITAL INC
FAQ
How long has WYNNEFIELD CAPITAL INC held LFCR?
WYNNEFIELD CAPITAL INC has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is WYNNEFIELD CAPITAL INC's current position in LFCR?
As of Q3 2026, WYNNEFIELD CAPITAL INC holds 4.87M shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $32.03M, representing 26.30% of its reported portfolio and ranking #1.
Has WYNNEFIELD CAPITAL INC been buying or selling LFCR?
In the latest 13F filing (Q3 2026), WYNNEFIELD CAPITAL INC increased its position in LFCR. The position peaked in Q4 2025 at 4.70M shares.
Which other funds hold LFCR?
Other major institutional holders of LFCR include Legion Partners Asset Management, LLC, 325 CAPITAL LLC, Greenhaven Road Investment Management, L.P., among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.